Disease | rheumatoid arthritis |
Comorbidity | C1565489|renal insufficiency |
Sentences | 1 |
PubMedID- 22807318 | Objective: to elucidate the safety of adalimumab for rheumatoid arthritis (ra) patients with renal insufficiency, including those with end-stage renal disease undergoing hemodialysis. |
Page: 1